Affiliation
Department of Medical Oncology, Christie Hospital, Manchester.Issue Date
2010-03-24T09:47:09Z
Metadata
Show full item recordAbstract
Paclitaxel was the first taxoid to become available. It was found to be an active anticancer agent but with significant toxicity. Docetaxel is a semisynthetic taxoid and the next of a fast-expanding class of drugs. Studies suggest that docetaxel may be more effective and less toxic than paclitaxel.Citation
Docetaxel., 57 (4):141-4 Br J Hosp MedJournal
British Journal of Hospital MedicinePubMed ID
9166374Type
ArticleLanguage
enISSN
0007-1064Collections
Related articles
- Docetaxel in anthracycline-resistant metastatic breast cancer.
- Authors: Hui YF, Ignoffo RJ
- Issue date: 1997 Mar-Apr
- The taxoids: same roots, different drugs.
- Authors: Von Hoff DD
- Issue date: 1997 Aug
- The taxoids. Comparative clinical pharmacology and therapeutic potential.
- Authors: Eisenhauer EA, Vermorken JB
- Issue date: 1998 Jan
- Paclitaxel and docetaxel in breast and ovarian cancer.
- Issue date: 1997 Jun
- Docetaxel (Taxotere): a highly active taxoid with manageable toxicity.
- Authors: Aapro MS
- Issue date: 1995 Apr